Actively Recruiting
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
Led by European Institute of Oncology · Updated on 2024-03-29
90
Participants Needed
1
Research Sites
224 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the study is to create a common and unique platform for the acquisition of biological samples and, subsequently, the possible identification of predictive and prognostic biomarkers for young adults with gastrointestinal and neuroendocrine cancers.The definition "adolescent and young adults (AYA)" covers a broad group of patients ranging from the upper limit of the paediatric competence to the youngest patients usually considered and treated as adults. However, a well-defined and universally accepted age range is still not established. Young adults with cancer have distinct epidemiological, biological, and clinical characteristics, as well as special medical and psychosocial needs that are often unmet. In consideration of their poor representation in clinical studies, as well as the rarer, albeit increasing, frequency at an epidemiological level, knowledge of the risk factors associated with cancers in young adults is very poor. It is therefore of fundamental importance to focus attention on this specific cohort of patients, in order to describe in ever more detail any specific biomolecular aspects, and make full use of the pharmacological resources currently available.
CONDITIONS
Official Title
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age at diagnosis from 18 to 39 years
- Carcinoma from any primary site including esophagus, stomach, pancreas, biliary tract, liver, small bowel, colon, rectum, anus, and cancer of unknown origin
- Neuroendocrine neoplasm from gastroenteropancreatic or lung/thymus origin
- Tumors at any stage at the first visit
- Tumors of any grade
- Histological diagnosis obtained within two years from enrollment or willingness to undergo a biopsy for diagnosis
You will not qualify if you...
- Age at diagnosis over 39 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, Italy
Actively Recruiting
Research Team
L
Lorenzo Gervaso, MD
CONTACT
C
Cristina Mazzon
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here